CO-INFECTION (HIV/TUBERCULOSIS) IN PREGNANT WOMEN
Abstract
The literature review describes the current state of the problem of the co-infection (HIV infection/tuberculosis) in pregnant women. Certain questions of tuberculosis detection and diagnostics in pregnant HIV-infected women were discussed. Approaches to treatment of drug susceptible and drug resistant tuberculosis in pregnant HIV-infected women were described with the reference to potential drug interaction. The literature review included the part devoted to specific diagnostics of congenital tuberculosis in children born by mothers with the co-infection. The need of further investigation of the actual issues of HIV/tuberculosis co-infection in the pregnant was highlighted.
About the Authors
I. B. Viktorova
Novokuznetsk State Institute for Medical Post-Graduate Training
Russian Federation
Novokuznetsk
Russian Federation
Novokuznetsk
A. V. Nesterenko
Krasnoyarsk Regional TB Dispensary no. 1
Russian Federation
Krasnoyarsk
Russian Federation
Krasnoyarsk
V. N. Zimina
People’s Friendship University of Russia
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Bogdanova E.V., Kiselevich O.K., Yusubova А.N. et al. Congenital tuberculosis. Tub., 2012, no. 1, pp. 54-59. (In Russ.)
2. Zimina V.N., Savitskaya N.G., Sheshelyakina N.N. Course of pregnancy, delivery and perinatal outcomes in HIV positive women with active tuberculosis Tub., 2014, no. 9, pp. 21-22. (In Russ.)
3. Kayukova S.I., Stakhanov V.А., Makarov O.V. Pregnancy and tuberculosis - current state of the problem. Probl. Tub., 2003, no. 9, pp. 31-35. (In Russ.)
4. Kravchenko E., Mordyk А., Valeeva G. et al. Favorable pregnancy outcome in women ill with tuberculosis: myth or reality? Vrach, 2015, no. 1, pp. 5-8. (In Russ.)
5. Ковганко П.А. On the problem of tuberculosis and maternity. Probl. Tub., 2003, no. 4, pp. 46-48. (In Russ.)
6. Lyutina E.I., Manerov F.K. The clinical case of congenital tuberculosis. Tub., 2014, no. 3, pp. 64-66. (In Russ.)
7. Edict no. 892 as of 25.12.2001 by RF Government On the Implementation of the Federal Law On Tuberculosis Transmission Prevention in the Russian Federation. (Collection of the Russian Laws, 2001, no. 53 (2.2), pp. 5185). (In Russ.)
8. Edict no. 736 by RF MoH as of 05.12.2007 On the Approval of the Medical Indications List for Induced Abortion. (In Russ.)
9. Rymanenko N.V. Specific course of the congenital co-infection of HIV/TB in newborns and infants. Tuberkul’oz, Legenevі Khvorobi, VІL-Infektsіya: Ukr. Nauk.-Prakt. Zhurn., 2013, no. 4, pp. 115-119. (In Ukr.)
10. Ryazantsev A.A. HIV-infection: ultrasound changes in the pregnant and children in the early neonatal period. Ultrazv. i Funktsional. Diagnostika, 2003, no. 3, pp. 32-41. (In Russ.)
11. Sapargalieva А.D., Grinberg V.B., Goncharova А.V. et al. Lethal cases among children in case of primary tuberculosis. Sb. materialov konferentsii Effektivnoe reshenie problemy TB: ot nauchnoy idei k meditsinskoy praktike. [Coll. of materials on the Conference on Effective Resolution of TB Problems: from Research to Medical Practice]. Novosibirsk, 2014, pp. 202-204. (In Russ.)
12. Tavrovskaya V.I., Khanin А.L. TB, pregnancy and HIV-infection (local situation and big problems). Sb. materialov konferentsii Effektivnoe reshenie problemy TB: ot nauchnoy idei k meditsinskoy praktike. [Coll. of materials on the Conference on Effective Resolution of TB Problems: from Research to Medical Practice]. Novosibirsk, 2014, pp. 224-227. (In Russ.)
13. Tuberkulez u detei i podrostkov. Rukovodstvo dlya vrachey. [Tuberculosis in children and adolescents. Guidelines for doctors]. Ed. by E.N. Yanchenko, M.S. Greymer, St. Petersburg, 1999, 335 p.
14. Tsinzerling V.А., Krasnogorskaya O.L., Vasil’eva M.V. et al. Perinatal pathology in HIV-infection. Arkhiv Patologii, 2005, vol. 67, no. 5, pp. 48-51. (In Russ.)
15. Abramowsky C.R., Gutman J., Hilinski J.A. Mycobacterium tuberculosis infection of the placenta: a study of the early (innate) inflammatory response in two cases. Pediat. Dev. Pathol., 2012, no. 15 (2), pp. 132-136.
16. Adhikari M., Pillay T., Pillay D.G. Tuberculosis in the newborn: an emerging disease. Pediatr. Infect. Dis. J., 1997, no. 16, pp. 1108-1112.
17. Ahmed Y., Mwaba P., Chintu C. et al. A study of maternal mortality at the university teaching hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int. J. Tuberc. Lung Dis., 1999, no. 3, pp. 675-680.
18. Arbex M.A., Varella M.C.L., Siqueira H.R. et al. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second-line drugs. J. Bras. Pneumol., 2010, no. 36 (5), pp. 641-656.
19. Balasubramanian S., Shivram R., Padmasani L.N. et al. Congenital tuberculosis. Indian. J. Pediatr., 1999, no. 66, pp. 148-150.
20. Bernard B., Abate M., Thielen P.F. et al. Maternal-fetal pharmacological activity of amikacin. J. Infect. Dis., 1977, no. 135, pp. 925-932.
21. Bloch A.B. Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the advisory council for the elimination of tuberculosis. MMWR Recomm. Rep., 1995, no. 44, pp. 18-34.
22. Blumberg H.M., Burman W.J., Chaisson R.E. et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med., 2003, no. 167, pp. 603-662.
23. Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf., 2001, no. 24, pp. 553-565.
24. Brost B.C., Newman R.B. The maternal and fetal effects of tuberculosis therapy. Obstet. Gynecol. Clin. North Am., 1997, no. 24 (3), pp. 659-673.
25. Burman W.J. Issues in the management of HIV-related tuberculosis. Clin. Chest Med., 2005, vol. 26, no. 2, pp. 283-294.
26. Centers for Disease Control and Prevention. Managing drug interactions in the ireatment of HIV-related tuberculosis [online]. 2013. Available from URL: http://www.cdc.gov/tb/TB_HIV_Drugs/default.htm;
27. Centers for Disease Control and Prevention. Provisional CDC Guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis. MMWR Recomm. 2013, no. 62(RR-09), pp. 1-12.
28. Centers for Disease Control and Prevention. Treatment of tuberculosis. MMWR. 2003, vol. 52, no. RR-11, pp. 1-77.
29. Centers for Disease Control and Prevention. Trends in tuberculosis. United States, 2010, MMWR Morb. Mortal Wkly Rep., 2012, no. 61, pp. 181-185.
30. Central TB Division, Managing the Revised National Tuberculosis Control Programme in your area - A training course; Modules 1-4, New Delhi, India, 2010.
31. Figueroa-Damian R., Arredondo-Garcia J.L. Pregnancy and tuberculosis: influence of treatment on perinatal outcome. Am.J. Perinat., 1998, no. 15, pp. 303-306.
32. Figueroa-Damian R., Arredondo-Garcıa J.L. Neonatal outcome of children born to women with tuberculosis. Arch. Med. Res., 2001, no. 32, pp. 66-69.
33. Getahun H., Sculier D., Sismanidis C. et al. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J.Infect. Dis., 2012, no. 205, Suppl. 2, pp. S216-S227.
34. Global tuberculosis control: WHO report 2011. Geneva, Switzerland, WHO, 2011, 248 p.
35. Grange J., Adhikari M., Ahmed Y. et al. Tuberculosis in association with HIV/AIDS emerges as a major nonobstetric cause of maternal mortality in sub-Saharan Africa. Int. J. Gynaecol. Obstet., 2010, no. 108, pp. 181-183.
36. Grisaru-Soen G., Savyon M., Sadot E. et al. Congenital tuberculosis and management of exposure in neonatal and pediatric intensive care units. Int. J. Tuberc. Lung. Dis., 2014, no. 18 (9), pp. 1062-1065.
37. Gupta A., Bhosale R., Kinikar A. et al. Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus. J. Infect. Dis., 2011, no. 203 (3), pp. 358-363.
38. Gupta A., Chandrasekhar A., Gupte N. et al. Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis. Clin. Infect. Dis., 2011, no. 53, pp. 1015-1018.
39. Gupta A., Navak U., Ram M. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin. Infect. Dis., 2007, no. 15, pp. 241-249.
40. Hageman J., Shulman S., Schreiber M. et al. Congenital tuberculosis: critical reappraisal of clinical findings and diagnostic procedures. Pediatrics, 1980, no. 66, pp. 980-984.
41. Hanrahan C.F., Westreich D., Van Rie A. Verification bias in a diagnostic accuracy study of symptom screening for tuberculosis in HIV-infected pregnant women. Clin. Infect. Dis., 2012, no. 9, pp. 1377-1378.
42. Hassan G., Qureshi W., Kadri S.M. Congenital Tuberculosis. JK SCIENCE, 2006, vol. 8, no. 4, pp. 193-194.
43. Health Protection Agency, Pregnancy and Tuberculosis: Guidance for Clinicians. Health Protection Agency. London, UK, 2006,
44. Hesseling A.C., Cotton M.F., Jennings T. et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin.Infect. Dis., 2009, no. 48, pp. 108-114.
45. Jamieson D.J., Theiler R.N., Rasmussen S.A. Emerging infections and pregnancy. Emerg. Infect. Dis., 2006, no. 12, pp. 1638-1643.
46. Jana N., Barik S., Arora N. Tuberculosis in pregnancy – a major maternal and perinatal challenge. BJOG, 2011, no. 118 (9), pp. 1145-1146.
47. Jana N., Vasishta K., Jindal S.K. et al. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int. J. Gynaecol., Obstet. 1994, vol. 44, no. 2, pp. 119-124.
48. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and managementof tuberculiosis in the United Kingdom: recommendations 1998. Thorax, 1998, no. 53, pp. 536-518.
49. Khan M., Pillay T., Moodley J.M. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS, 2001, no. 15, pp. 1857-1863.
50. Lange C., Abubakar I., Alffenaar J.W.C. et al. for the TBNET. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis
51. in Europe: a TBNET consensus statement. Eur. Respir J., 2014, no. 44 (1), pp. 23-63.
52. Lee L.H., LeVea C.M., Graman P.S. Congenital Tuberculosis in a neonatal intensive care unit: case report, epidemiological inveтstigation, and management of exposures. CID, 1998, no. 27, pp. 474-477.
53. Lessnau K.D., Qarah S. Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature. Chest, 2003, no. 123, pp. 953-956.
54. Lewelyn M., Cropley I., Wilkinson R.J. et al. Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax, 2000, no. 55, pp. 129-132.
55. Loto O.M., Awowole I. Tuberculosis in Pregnancy: a review. J. Pregnancy, 2012, Article ID 379271, 7.
56. Management, control and prevention of tuberculosis; Guidelines for health care providers (2002-2005), Department of Human Services, Victoria, Australia, 2002.
57. Manji K.P., Msemo G., Tamim B. et al. Tuberculosis (presumed congenital) in a neonatal unit in Dar-es-Salaam. J. Trop. Pediatr., 2001, no. 47, pp. 153-155.
58. Mathad J.S., Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin. Infect. Dis., 2012, no. 55, pp. 1532-1549.
59. Mazurek G.H., Jereb J., Vernon A. et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm. Rep., 2010, no. 59 (RR-5). pp. 1-25.
60. McCarthy F.P., Rowlands S., Giles M. Tuberculosis in pregnancy - case studies and a review of Australia’s screening process. Aust. N. Z. J. Obstet. Gynaecol., 2006, no. 46, pp. 451-455.
61. Mnyani C.N., McIntyre J.A. Tuberculosis in pregnancy. BJOG, 2011, no. 118 (2), pp. 226-231.
62. Nabulsi B.K., Kadi M., AlAbadi H. et al. Pregnant women with fulminant disseminated TB to the omentum and placenta. Gynecol. Obstet.(Sunnyvale), 2014, no. 4, pp. 225.
63. Neyrolles O., Quintana-Murci L. Sexual inequality in tuberculosis. PLos Med., 2009, no. 6 (12), pp. e1000199.
64. Özcan B., Ener Ç.D., Kadir K. et al. Congenital tuberculosis with multisystem involvement: a case report. Turkish Respir. J., 2007, no. 8 (1), pp. 36-38.
65. Palacios E., Dallman R., Muñoz M. et al. Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru. Clin. Infect. Dis., 2009, no. 15, vol. 48, no. 10, pp. 1413-1419.
66. Piccinni M.P. T-cell tolerance towards the fetal allograft. J. Reprod. Immunol., 2010, no. 85, pp. 71-75.
67. Pickering L.K., Baker C.J., Long S.S. et al. Red Book: 2006 report of the committee on infectious diseases, American Academy of Pediatrics, Elk Grove Village, IL, USA, 28th edition, 2009. pp. 988.
68. Pillay T., Adhikari M., Mokili J. et al. Severe, rapidly progressive human immunodeficiency virus type 1 disease in newborns with coinfections. Pediatr. Infect. Dis. J., 2001, no. 20, pp. 404-410.
69. Pillay T., Jeena P.M. A neonate with haemorrhagic ascites. Lancet, 1999, no. 354, pp. 914.
70. Pillay T., Khan M., Moodley J. et al. Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect. Dis., 2004, no. 4, pp. 155-165.
71. Pillay T., Sturm A.W., Khan M. et al. Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection. Int.J. Tuberc. Lung Dis., 2004, no. 8 (1), pp. 59-69.
72. Ratner B., Rostler A.E., Salgado P.S. Care, feeding and fate of premature and full term infants born of tuberculous mothers. AMA Am. J. Dis. Child, 1951, no. 81, pp. 471-482.
73. Ribeiro P.S., Jacobsen K.H., Mathers C.D. et al. Priorities for women’s health from the global burden of disease study. Int. J. Gynaecol. Obstet., 2008, no. 102 (1), pp. 82-90.
74. Shin S., Guerra D., Rich M. et al. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases. Clin.Infect. Dis., 2003, no. 36, pp. 996-1003.
75. Singh N., Perfect J.R. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin. Infect. Dis., 2007, no. 45, pp. 1192-1199.
76. Smith K.C. Congenital tuberculosis: a rare manifestation of a common infection. Current Opin. Ped., 2002, no. 15, pp. 269-274.
77. Snider D. Pregnancy and tuberculosis. Chest, 1984, no. 86, pp. 10S-13S.
78. Snider D., Bloch A. Congenital tuberculosis. Tubercle, 1984, no. 65, pp. 81-82.
79. Starke J.R. An old disease but a new threat to the mother, fetus, and neonate. Clin. Perinatol., 1997, no. 24, pp. 107-127.
80. Tabarsi P., Moradi A., Baghaei P. et al. Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy. Int. J. Tuberc. Lung Dis., 2011, no. 15, pp. 547-550.
81. Taylor A.W., Mosimaneotsile D., Mathebula U. et al. Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy. Infect.Dis.Obstet.Gynecol., 2013, Article ID 195637.
82. Toppenberg K.S., Hill D.A., Miller D.P. Safety of radiographic imaging during pregnancy. Am. Fam. Physician., 1999, no. 59, pp. 1813-1818.
83. Tripaty S.N. Tuberculosis and pregnancy. Int. J. Gynaecol. Obstet., 2003, no. 80, pp. 247-253.
84. Vallejo J.G., Starke J.R. Tuberculosis and pregnancy. Clin. Chest Med., 1992, vol. 13, no. 4, pp. 693-707.
85. Wang S.L., Coonley F. Occurrence of tubercle bacilli in breast milk of tuberculous women. JAMA, 1917, no. 69, pp. 531-532.
86. Warthin A.S. Miliary tuberculosis of the placenta with incipient pulmonary tuberculosis of the mother becoming latent after birth of child. JAMA, 1913, no. 61 (22), pp. 1951-1952.
87. Wilsher M.L., Hagan C., Prestidge R. et al. Human in vitro immune responses to Mycobacterium tuberculosis. Tuber. Lung Dis., 1999, no. 79, pp. 371-377.
88. Woltz J., Wiley M. Transmission of streptomycin from maternal blood to the fetal circulation and amniotic fluid. Proc. Soc.Exp.Biol.Med., 1945, no. 60, pp. 106-107.
89. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland, WHO, 2011, 40 p.
90. World Health Organization. Strategic and technical advisory group (STAG-TB).
91. Geneva, Switzerland, WHO, 2010, 28 p.
92. World Health Organization. Treatment of tuberculosis guidelines. 4th ed. Geneva, Switzerland, WHO, 2010, 148 p.
93. Zenner D., Kruijshaar M.E., Andrews N. et al. Risk of tuberculosis in pregnancy: a national, primary care based cohort and self-controlled case series study. Am. J. Respir. Crit. Care Med., 2012, no. 185, pp. 779-784.
94. Zhao Y., Ying H., Demei J. et al. Tuberculosis and sexual inequality: the role of sex hormones in immunity. Crit. Rev. Eukariyot. Gene Expr., 2012, no. 22 (3), pp. 233-241.
Review
For citations:
Viktorova I.B., Nesterenko A.V., Zimina V.N. CO-INFECTION (HIV/TUBERCULOSIS) IN PREGNANT WOMEN. Tuberculosis and Lung Diseases. 2015;(12):8-18. (In Russ.)
Views:
1218
Email this article 